The trajectory of companies tied to blockbuster drugs like Viagra presents a nuanced investment picture. While the initial boom of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the expiry in key territories has introduced considerable volatility. Investors are now facing the consequences of lower-cost altern